Spyre Therapeutics
SYRE
#4915
Rank
$1.19 B
Marketcap
$23.51
Share price
3.52%
Change (1 day)
147.47%
Change (1 year)

Revenue for Spyre Therapeutics (SYRE)

Revenue in 0 (TTM): N/A

According to Spyre Therapeutics's latest financial reports the company's current revenue (TTM) is $0.68 M. .The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spyre Therapeutics from to

Annual revenue

Year Revenue Change